The management of vulval cancer

Cancer Treatment Reviews

Volumn 35, Issue 7, 2009, Pages 533-539

  Crosbie, Emma J ^a   Slade, Richard J ^a   Ahmed, Ahmed S ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Advanced vulval cancer; Recurrent vulval cancer; Sentinel lymph node; Vulval cancer

Indexed keywords

BLEOMYCIN; CISPLATIN; FLUOROURACIL; MITOMYCIN C;

ADVANCED CANCER; CANCER INVASION; CANCER RECURRENCE; CLINICAL TRIAL; DISEASE FREE SURVIVAL; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHEDEMA; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PATIENT SATISFACTION; PREOPERATIVE RADIOTHERAPY; PROGNOSIS; QUALITY OF LIFE; REVIEW; SENTINEL LYMPH NODE BIOPSY; SKIN NECROSIS; SURGICAL TECHNIQUE; SURVIVAL RATE; VULVA CANCER; VULVECTOMY;

FEMALE; HUMANS; PROGNOSIS; VULVAR NEOPLASMS;

EID: 70350225825     PISSN: 03057372     EISSN: 15321967     Source Type: Journal    
DOI: 10.1016/j.ctrv.2009.01.005     Document Type: Review

References (83)

1. Office for National Statistics. www.statistics.gov.uk; 2000.
2. Hacker N.F. Vulvar cancer. In: Berek J.S., and Hacker N.F. (Eds). Practical gynaecologic oncology. 3rd ed. (2000), Williams and Wilkins, Baltimore p. 553-96
3. Ghurani G.B., and Penalver M.A. An update on vulvar cancer. Am J Obstet Gynecol 185 2 (2001) 294-299
4. Allen J. The clinical nurse specialist in gynaecological oncology-the role in vulval cancer. Best Pract Res Clin Obstet Gynaecol 17 4 (2003) 591-607
5. Leminen A., Forss M., and Paavonen J. Wound complications in patients with carcinoma of the vulva. Comparison between radical and modified vulvectomies. Eur J Obstet Gynecol Reprod Biol 93 2 (2000) 193-197
6. Magrina J.F., Gonzalez-Bosquet J., Weaver A.L., et al. Primary squamous cell cancer of the vulva: radical versus modified radical vulvar surgery. Gynecol Oncol 71 1 (1998) 116-121
7. Kelley III J.L., Burke T.W., Tornos C., et al. Minimally invasive vulvar carcinoma: an indication for conservative surgical therapy. Gynecol Oncol 44 3 (1992) 240-244
8. Hacker N.F., Leuchter R.S., Berek J.S., Castaldo T.W., and Lagasse L.D. Radical vulvectomy and bilateral inguinal lymphadenectomy through separate groin incisions. Obstet Gynecol 58 5 (1981) 574-579
9. Barton D.P. The prevention and management of treatment related morbidity in vulval cancer. Best Pract Res Clin Obstet Gynaecol 17 4 (2003) 683-701
10. de Hullu J.A., and van der Zee A.G. Groin surgery and the sentinel lymph node. Best Pract Res Clin Obstet Gynaecol 17 4 (2003) 571-589
11. Zhang X., Sheng X., Niu J., et al. Sparing of saphenous vein during inguinal lymphadenectomy for vulval malignancies. Gynecol Oncol 105 3 (2007) 722-726
12. DiSaia P.J., Creasman W.T., and Rich W.M. An alternate approach to early cancer of the vulva. Am J Obstet Gynecol 133 7 (1979) 825-832
13. Chu J., Tamimi H.K., and Figge D.C. Femoral node metastases with negative superficial inguinal nodes in early vulvar cancer. Am J Obstet Gynecol 140 3 (1981) 337-339
14. Stehman F.B., Bundy B.N., Dvoretsky P.M., and Creasman W.T. Early stage I carcinoma of the vulva treated with ipsilateral superficial inguinal lymphadenectomy and modified radical hemivulvectomy: a prospective study of the Gynecologic Oncology Group. Obstet Gynecol 79 4 (1992) 490-497
15. van Der Velden J, Ansink A. Primary groin irradiation vs primary groin surgery for early vulvar cancer. Cochrane Database Syst Rev 2000;(3):CD002224.
16. Hallak S., Ladi L., and Sorbe B. Prophylactic inguinal-femoral irradiation as an alternative to primary lymphadenectomy in treatment of vulvar carcinoma. Int J Oncol 31 5 (2007) 1077-1085
17. Heaps J.M., Fu Y.S., Montz F.J., Hacker N.F., and Berek J.S. Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynecol Oncol 38 3 (1990) 309-314
18. Chan J.K., Sugiyama V., Pham H., et al. Margin distance and other clinico-pathologic prognostic factors in vulvar carcinoma: a multivariate analysis. Gynecol Oncol 104 3 (2007) 636-641
19. Gotlieb W.H. The assessment and surgical management of early-stage vulvar cancer. Best Pract Res Clin Obstet Gynaecol 17 4 (2003) 557-569
20. Piura B., Rabinovich A., Cohen Y., Friger M., and Glezerman M. Squamous cell carcinoma of the vulva in the south of Israel: a study of 50 cases. J Surg Oncol 67 3 (1998) 174-181
21. Ahuja A., Ying M., Yang W.T., Evans R., King W., and Metreweli C. The use of sonography in differentiating cervical lymphomatous lymph nodes from cervical metastatic lymph nodes. Clin Radiol 51 3 (1996) 186-190
22. Ahuja A., Ying M., Yuen Y.H., and Metreweli C. Power Doppler sonography of cervical lymphadenopathy. Clin Radiol 56 12 (2001) 965-969
23. Hall T.B., Barton D.P., Trott P.A., et al. The role of ultrasound-guided cytology of groin lymph nodes in the management of squamous cell carcinoma of the vulva: 5-year experience in 44 patients. Clin Radiol 58 5 (2003) 367-371
24. Moskovic E.C., Shepherd J.H., Barton D.P., Trott P.A., Nasiri N., and Thomas J.M. The role of high resolution ultrasound with guided cytology of groin lymph nodes in the management of squamous cell carcinoma of the vulva: a pilot study. Br J Obstet Gynaecol 106 8 (1999) 863-867
25. Sohaib S.A., and Moskovic E.C. Imaging in vulval cancer. Best Pract Res Clin Obstet Gynaecol 17 4 (2003) 543-556
26. Bipat S., Fransen G.A., Spijkerboer A.M., et al. Is there a role for magnetic resonance imaging in the evaluation of inguinal lymph node metastases in patients with vulva carcinoma?. Gynecol Oncol 103 3 (2006) 1001-1006
27. Sohaib S.A., Richards P.S., Ind T., et al. MR imaging of carcinoma of the vulva. AJR Am J Roentgenol 178 2 (2002) 373-377
28. Dooms G.C., Hricak H., Moseley M.E., Bottles K., Fisher M., and Higgins C.B. Characterization of lymphadenopathy by magnetic resonance relaxation times: preliminary results. Radiology 155 3 (1985) 691-697
29. Hawnaur J.M., Reynolds K., Wilson G., Hillier V., and Kitchener H.C. Identification of inguinal lymph node metastases from vulval carcinoma by magnetic resonance imaging: an initial report. Clin Radiol 57 11 (2002) 995-1000
30. Singh K., Orakwue C.O., Honest H., Balogun M., Lopez C., and Luesley D.M. Accuracy of magnetic resonance imaging of inguinofemoral lymph nodes in vulval cancer. Int J Gynecol Cancer 16 3 (2006) 1179-1183
31. Tabatabaei S., Harisinghani M., and McDougal W.S. Regional lymph node staging using lymphotropic nanoparticle enhanced magnetic resonance imaging with ferumoxtran-10 in patients with penile cancer. J Urol 174 3 (2005) 923-927
32. Vilarino-Varela M.J., Taylor A., Rockall A.G., Reznek R.H., and Powell M.E. A verification study of proposed pelvic lymph node localisation guidelines using nanoparticle-enhanced magnetic resonance imaging. Radiother Oncol (2008)
33. Cohn D.E., Dehdashti F., Gibb R.K., et al. Prospective evaluation of positron emission tomography for the detection of groin node metastases from vulvar cancer. Gynecol Oncol 85 1 (2002) 179-184
34. De Hullu J.A., Pruim J., Que T.H., et al. Noninvasive detection of inguinofemoral lymph node metastases in squamous cell cancer of the vulva by L. Int J Gynecol Cancer 9 2 (1999) 141-146
35. Land R., Herod J., Moskovic E., et al. Routine computerized tomography scanning, groin ultrasound with or without fine needle aspiration cytology in the surgical management of primary squamous cell carcinoma of the vulva. Int J Gynecol Cancer 16 1 (2006) 312-317
36. Levenback C.F. How safe is sentinel lymph node biopsy in patients with vulvar cancer?. J Clin Oncol 26 6 (2008) 828-829
37. de Hullu J.A., Ansink A.C., Tymstra T., and van der Zee A.G. What doctors and patients think about false-negative sentinel lymph nodes in vulvar cancer. J Psychosom Obstet Gynaecol 22 4 (2001) 199-203
38. Martinez-Palones J.M., Perez-Benavente M.A., Gil-Moreno A., et al. Comparison of recurrence after vulvectomy and lymphadenectomy with and without sentinel node biopsy in early stage vulvar cancer. Gynecol Oncol 103 3 (2006) 865-870
39. Van der Zee A.G., Oonk M.H., De Hullu J.A., et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol 26 6 (2008) 884-889
40. de Hullu JA, Oonk MH, Ansink AC, Hollema H, Jager PL, van der Zee AG. Pitfalls in the sentinel lymph node procedure in vulvar cancer. Gynecol Oncol 2004;94(1):10-5.
41. de Hullu J.A., Hollema H., Piers D.A., et al. Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva. J Clin Oncol 18 15 (2000) 2811-2816
42. Puig-Tintore L.M., Ordi J., Vidal-Sicart S., et al. Further data on the usefulness of sentinel lymph node identification and ultrastaging in vulvar squamous cell carcinoma. Gynecol Oncol 88 1 (2003) 29-34
43. Terada K.Y., Shimizu D.M., and Wong J.H. Sentinel node dissection and ultrastaging in squamous cell cancer of the vulva. Gynecol Oncol 76 1 (2000) 40-44
44. de Hullu J.A., Piers D.A., Hollema H., Aalders J.G., and van der Zee A.G. Sentinel lymph node detection in locally recurrent carcinoma of the vulva. Bjog 108 7 (2001) 766-768
45. Gaarenstroom K.N., Kenter G.G., Trimbos J.B., et al. Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisions. Int J Gynecol Cancer 13 4 (2003) 522-527
46. Hefler L.A., Grimm C., Six L., et al. Inguinal sentinel lymph node dissection vs complete inguinal lymph node dissection in patients with vulvar cancer. Anticancer Res 28 1 (2008) 515-517
47. Rouzier R., Haddad B., Dubernard G., Dubois P., and Paniel B.J. Inguinofemoral dissection for carcinoma of the vulva: effect of modifications of extent and technique on morbidity and survival. J Am Coll Surg 196 3 (2003) 442-450
48. Hoffman M.S. Squamous-cell carcinoma of the vulva: locally advanced disease. Best Pract Res Clin Obstet Gynaecol 17 4 (2003) 635-647
49. Hoffman M.S., Cavanagh D., Roberts W.S., Fiorica J.V., and Finan M.A. Ultraradical surgery for advanced carcinoma of the vulva: an update. Int J Gynecol Cancer 3 6 (1993) 369-372
50. Barton D.P., Hoffman M.S., Roberts W.S., et al. Use of local flaps in the preservation of fecal continence following resection of perianal neoplasias. Int J Gynecol Cancer 3 5 (1993) 318-323
51. Reid G.C., DeLancey J.O., Hopkins M.P., Roberts J.A., and Morley G.W. Urinary incontinence following radical vulvectomy. Obstet Gynecol 75 5 (1990) 852-858
52. Hockel M., and Dornhofer N. Vulvovaginal reconstruction for neoplastic disease. Lancet Oncol 9 6 (2008) 559-568
53. van Doorn HC, Ansink A, Verhaar-Langereis M, Stalpers L. Neoadjuvant chemoradiation for advanced primary vulvar cancer. Cochrane Database Syst Rev 2006;3:CD003752.
54. Beriwal S., Coon D., Heron D.E., et al. Preoperative intensity-modulated radiotherapy and chemotherapy for locally advanced vulvar carcinoma. Gynecol Oncol 109 2 (2008) 291-295
55. Moore D.H., Thomas G.M., Montana G.S., Saxer A., Gallup D.G., and Olt G. Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group. Int J Radiat Oncol Biol Phys 42 1 (1998) 79-85
56. Luesley DM, Lopes AD. Management of vulval cancer, vol. 1. London: Royal College of Obstetricians and Gynaecologists; 2006. p. 11-28.
57. Montana G.S., Thomas G.M., Moore D.H., et al. Preoperative chemo-radiation for carcinoma of the vulva with N2/N3 nodes: a gynecologic oncology group study. Int J Radiat Oncol Biol Phys 48 4 (2000) 1007-1013
58. Blake P. Radiotherapy and chemoradiotherapy for carcinoma of the vulva. Best Pract Res Clin Obstet Gynaecol 17 4 (2003) 649-661
59. Schreer I. Cancer of the vulva: primary irradiation. In: Vahrson H.W. (Ed). Radiation Oncology of Gynecological Cancers (1997), Springer, Berlin p. 82-9
60. Landrum L.M., Skaggs V., Gould N., Walker J.L., and McMeekin D.S. Comparison of outcome measures in patients with advanced squamous cell carcinoma of the vulva treated with surgery or primary chemoradiation. Gynecol Oncol 108 3 (2008) 584-590
61. Berek J.S., Heaps J.M., Fu Y.S., Juillard G.J., and Hacker N.F. Concurrent cisplatin and 5-fluorouracil chemotherapy and radiation therapy for advanced-stage squamous carcinoma of the vulva. Gynecol Oncol 42 3 (1991) 197-201
62. Koh W.J., Wallace III H.J., Greer B.E., et al. Combined radiotherapy and chemotherapy in the management of local-regionally advanced vulvar cancer. Int J Radiat Oncol Biol Phys 26 5 (1993) 809-816
63. Russell A.H., Mesic J.B., Scudder S.A., et al. Synchronous radiation and cytotoxic chemotherapy for locally advanced or recurrent squamous cancer of the vulva. Gynecol Oncol 47 1 (1992) 14-20
64. Thomas G., Dembo A., DePetrillo A., et al. Concurrent radiation and chemotherapy in vulvar carcinoma. Gynecol Oncol 34 3 (1989) 263-267
65. Faul C.M., Mirmow D., Huang Q., Gerszten K., Day R., and Jones M.W. Adjuvant radiation for vulvar carcinoma: improved local control. Int J Radiat Oncol Biol Phys 38 2 (1997) 381-389
66. Homesley H.D., Bundy B.N., Sedlis A., and Adcock L. Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes. Obstet Gynecol 68 6 (1986) 733-740
67. Hopkins M.P., Reid G.C., and Morley G.W. The surgical management of recurrent squamous cell carcinoma of the vulva. Obstet Gynecol 75 6 (1990) 1001-1005
68. Maggino T., Landoni F., Sartori E., et al. Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicenter CTF Study. Cancer 89 1 (2000) 116-122
69. Piura B., Masotina A., Murdoch J., Lopes A., Morgan P., and Monaghan J. Recurrent squamous cell carcinoma of the vulva: a study of 73 cases. Gynecol Oncol 48 2 (1993) 189-195
70. Simonsen E. Treatment of recurrent squamous cell carcinoma of the vulva. Acta Radiol Oncol 23 5 (1984) 345-348
71. Tilmans A.S., Sutton G.P., Look K.Y., Stehman F.B., Ehrlich C.E., and Hornback N.B. Recurrent squamous carcinoma of the vulva. Am J Obstet Gynecol 167 5 (1992) 1383-1389
72. Weikel W., Schmidt M., Steiner E., Knapstein P.G., and Koelbl H. Surgical therapy of recurrent vulvar cancer. Am J Obstet Gynecol 195 5 (2006) 1293-1302
73. De Hullu J.A., Hollema H., Lolkema S., et al. Vulvar carcinoma. The price of less radical surgery. Cancer 95 11 (2002) 2331-2338
74. Rouzier R., Haddad B., Plantier F., Dubois P., Pelisse M., and Paniel B.J. Local relapse in patients treated for squamous cell vulvar carcinoma: incidence and prognostic value. Obstet Gynecol 100 6 (2002) 1159-1167
75. Salom E.M., and Penalver M. Recurrent vulvar cancer. Curr Treat Options Oncol 3 2 (2002) 143-153
76. Hopkins M.P., and Morley G.W. Pelvic exenteration for the treatment of vulvar cancer. Cancer 70 12 (1992) 2835-2838
77. Miller B., Morris M., Levenback C., Burke T.W., and Gershenson D.M. Pelvic exenteration for primary and recurrent vulvar cancer. Gynecol Oncol 58 2 (1995) 202-205
78. Coulter J., and Gleeson N. Local and regional recurrence of vulval cancer: management dilemmas. Best Pract Res Clin Obstet Gynaecol 17 4 (2003) 663-681
79. Gould N., Kamelle S., Tillmanns T., et al. Predictors of complications after inguinal lymphadenectomy. Gynecol Oncol 82 2 (2001) 329-332
80. Hoffman M.S., Mark J.E., and Cavanagh D. A management scheme for postoperative groin lymphocysts. Gynecol Oncol 56 2 (1995) 262-265
81. van der Velden J., van Lindert A.C., Lammes F.B., et al. Extracapsular growth of lymph node metastases in squamous cell carcinoma of the vulva. The impact on recurrence and survival. Cancer 75 12 (1995) 2885-2890
82. Rowley K.C., Gallion H.H., Donaldson E.S., et al. Prognostic factors in early vulvar cancer. Gynecol Oncol 31 1 (1988) 43-49
83. Homesley HD, Bundy BN, Sedlis A, et al. Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a Gynecologic Oncology Group study). Am J Obstet Gynecol 1991;164(4):997-1003 [discussion 1003-4].